Nanomedicine News

RSS

Abraxis BioScience to Present Multiple Clinical Studies of ABRAXANE at 45th ASCO

Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, today announced that multiple clinical studies of the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound...

13 May 2009

First Implantable Device Monitor How Tumors Respond to Treatment

Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.

12 May 2009

Nanotechnology Scientists Win Microgravity Research Competition

When a spacecraft launches from Cape Canaveral, Fla., in the future, its cargo will include a small box containing a nano-fluidics experiment designed by scientists at The University of Texas Health Science Center at Houston.

12 May 2009

Simpler, Less Expensive Design Could Make Precision Particle Therapy Available to More Patients

As part of an effort to make high-precision particle cancer therapy accessible to more patients, a physicist at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory has developed a simpler, less-expensive gantry design for delivering tumor-killing particle beams.

12 May 2009

Diasome Pharmaceuticals Selected for Presentation at 69th Scientific Sessions of ADA

Diasome Pharmaceuticals, a clinical stage diabetes therapeutics company, today announced that its abstract was selected for presentation at the 69th Scientific Sessions of the American Diabetes Association (ADA), being h...

11 May 2009

Harvard Researchers Create New Type of Microscopic Swimmer

Harvard researchers have created a new type of microscopic swimmer: a magnetized spiral that corkscrews through liquids and is able to deliver chemicals and push loads larger than itself.

11 May 2009

Starpharma Signs Collaborative Research, License and Commercialisation Agreement with Elanco

Starpharma Holdings Limited (ASX: SPL) today announced the signing of a collaborative research, license and commercialisation agreement with Elanco, the animal health division of US pharmaceutical company Eli Lilly and C...

From Starpharma Holdings Ltd 11 May 2009

QMDx Signs License Agreement with Nanosys for Patents Applications Related to the Use of Nanowires for Biosensors

Nanosys Inc. and QuantuMDx Group (QMDx) today announced that QMDx has signed a non-exclusive license agreement with Nanosys for several patents and patent applications related to the use of nanowires for biosensors. T...

From Shoei Electronic Materials, Inc 11 May 2009

Journey into the Sub-Microscopic World of Molecular Machines

The Machinery of Life is a journey into the sub-microscopic world of molecular machines. Readers are introduced to the types of molecules within the cell, including proteins, nucleic acids, lipids and polysaccharides. Then, in a series of full-color illustrations, which show a portion of a living cell magnified 1,000,000 times, the reader is guided through the interior world of cells.

8 May 2009

Metabolon Announces Closure of $5.3 Million Series C Funding Round

Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced that it has closed $5.3 million of an anticipated $11 million Series C funding round. This first portion closed on Apri...

8 May 2009